9M21, AIS’ performance was in-line with the guidance, delivering a flat core service revenue due to on-going impact of the pandemic while reported slightly increase in EBITDA (+2% YoY). FY21 guidance is
core principles take into account environmental, social and governance (ESG) factors in the business practices of investee companies, offering institutional investors a balanced focus apart from seeking
blueprint is the result of thorough analysis and re-adjustment of focus. Each issue will be explored to the core with stakeholders? interest in mind to ensure right-to-the-point, effective problem solving
including non-communicable diseases such cardiovascular disease, neurologic diseases, emergency care etc. Cost of Hospital Operations The cost of hospital operations for the 1st quarter of Year 2017 and 2018
, emergency care etc. Cost of medical treatment The cost of medical treatment for the Year 2017 and 2018 were in amounts of Baht 382.27 millions and Baht 430.52 million, respectively, which increased by 12.6
of 30 September 2017 To : Managing Director Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the nine-month
Hygienic Medical Service with Knowledge Base Management by Sterilized Sanitation such as advice for skin care, esthetics, cosmetics distribution including related products under trade name, service mark
Knowledge Base Management by Sterilized Sanitation such as advice for skin care, esthetics, cosmetics distribution including related products under trade name, service mark, trade mark “Wuttisak Clinic” of
diseases, emergency care etc. Cost of Hospital Operations The cost of hospital operations for the 2nd quarter of Year 2017 and 2018 were in amounts of Baht 9 0 .6 9 millions and Baht 99.04 million
, neurologic diseases, emergency care etc. Cost of Hospital Operations The cost of hospital operations for the 3rd quarter of Year 2017 and 2018 were in amounts of Baht 95.14 millions and Baht 108.25 million